Thank you to the providers and health institutions that have partnered with us to reach this incredible milestone: Invitae has tested over 5 million patients. Because of our work together, those patients received genetic information to help inform medical decisions for themselves and their families. To learn more, visit invitae.com
Invitae’s Post
More Relevant Posts
-
This free pharmacist toolkit on benzodiazepine taper includes populations at risk for complications, screening and diagnosis, benzodiazepine withdrawal, treatment, special populations, harm reduction, clinical pearls, authors experience, and references. https://aapp.fyi/4ri
To view or add a comment, sign in
-
-
This free pharmacist toolkit on benzodiazepine taper includes populations at risk for complications, screening and diagnosis, benzodiazepine withdrawal, treatment, special populations, harm reduction, clinical pearls, authors experience, and references. https://aapp.fyi/4ri
To view or add a comment, sign in
-
-
This free pharmacist toolkit on benzodiazepine taper includes populations at risk for complications, screening and diagnosis, benzodiazepine withdrawal, treatment, special populations, harm reduction, clinical pearls, authors experience, and references. https://aapp.fyi/4ri
To view or add a comment, sign in
-
-
This free pharmacist toolkit on benzodiazepine taper includes populations at risk for complications, screening and diagnosis, benzodiazepine withdrawal, treatment, special populations, harm reduction, clinical pearls, authors experience, and references. https://aapp.fyi/4ri
To view or add a comment, sign in
-
-
Excited to share insights from our study! Comparing the effectiveness of electrotherapy and Ferguson hemorrhoidectomy in a randomized prospective study. Advancing knowledge in hemorrhoid treatment! #hemorrhoids #hemorapy #painless #dgdena #hemorrhoidectomy
To view or add a comment, sign in
-
Are we entering a new era for the treatment of (at least a subtype) of #parkinsondisease. There is room for optimism, as well as caution till we reasonably grasp the effects of GLP-1 agonists on pathogenic processes driving neuronal dysfunction in PD. For a long time, there was a dogma on peptic ulcer disease that it is caused by excessive acid in stomach. Now, we know that the condition can be treated in vast majority by antibiotics to eradicate H. pylori. I am afraid that we face similar dogmas in PD research (ie. role of excessive synuclein accumulation thought as the cause). We shared our reflections on this topic https://lnkd.in/dEgNDtdd
The full results of the phase 2 clinical trial of lixisenatide have now been published. This Cure Parkinson’s co-funded trial has reported positive results, indicating that the treatment may slow the progression of motor symptoms. Find out more: https://buff.ly/4aBOZN2 Van Andel Institute #CureParkinsons #Parkinsons #ParkinsonsResearch #ChangeTheFuture
To view or add a comment, sign in
-
-
Tomorrow at #RelapseConference23, we will present data showing hematologic protection in patients treated with trem-cel after repeat Mylotarg dosing. This data suggests that trem-cel shielded healthy cells from the on-target toxicity typically seen with Mylotarg treatment. Learn more: https://lnkd.in/epbEczwT Cc ASTCT The EBMT
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
To view or add a comment, sign in
-
This chapter provides a clinician-friendly summary of #reproductivegenetics. Currently, #geneticproblems and #genetictesting play a significant role in #reproductivemedicine, and this role is likely to grow significantly over the next decade. #clinicalgenetics #clinicalgenomics #genomicmedicine #humangenetics #medicalgenetics #rerproductivehealth
To view or add a comment, sign in
-
In what aspects can hemoadsorption therapy improve the clinical outcomes of viral pneumonia? Is the total amount of purified blood and number of treatment sessions correlated with survival rate? Please click the poster and the full paper link for more details: https://lnkd.in/eqwgSFGY #Jafron #hemoadsorption
To view or add a comment, sign in
-
-
AI technology + genomics = accelerating answers for patients and providers Join us in shaping the future of healthcare. Read on how Invitae is using AI to reduce variants of uncertain significance.
Invitae’s experts are committed to giving definitive answers to more patients, achieving a 40% reduction in variants of uncertain significance (VUS) observed in patients in just 3 years. Learn more about some of their methods: https://invit.ae/3vPjGiM #GeneticInsights
To view or add a comment, sign in
Adult Vaccines Sales Representative
1moCongratulations! Invitae is making such a difference in patients' lives.